Patent details

EP0914118 Title: SUBSTITUTED 3,5-DIPHENYL-1,2,4-TRIAZOLES AND THEIR USE AS PHARMACEUTICAL METAL CHELATORS

Basic Information

Publication number:
EP0914118
PCT Application Number:
PCT/EP/97/03315
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP979282696
PCT Publication Number:
WO/97/04939
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SUBSTITUTED 3,5-DIPHENYL-1,2,4-TRIAZOLES AND THEIR USE AS PHARMACEUTICAL METAL CHELATORS
French Title of Invention:
3,5-DIPHENYL-1,2,4-TRIAZOLES SUBSTITUES ET LEUR UTILISATION COMME CHELATEURS DE METAUX PHARMACEUTIQUES
German Title of Invention:
SUBSTITUIERTE 3,5-DIPHENYL-1,2,4-TRIAZOLE UND IHRE VERWENUNG ALS PHARMAZEUTISCHEMETALLCHELATOREN
SPC Number:
91291

Dates

Filing date:
24/06/1997
Grant date:
23/10/2002
EP Publication Date:
23/10/2002
PCT Publication Date:
31/12/1997
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/05/1999
EP B1 Publication Date:
23/10/2002
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
24/06/2017
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/06/1997
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
LATTMANN René
Address:
Switzerland (CH)

2

Name:
ACKLIN Pierre
Address:
Switzerland (CH)

Licencee

Name:
NOVARTIS PHARMA NV
From:
16/02/2022
Address:
Medialaan 40, 1800, Vilvoorde, Belgium (BE)
To:
16/02/2022

Priority

Priority Number:
159396
Priority Date:
25/06/1996
Priority Country:
Switzerland (CH)

Classification

Main IPC Class:
A61K 31/41;

Publication

Bulletin

Bulletin Heading:
MED
Bulletin edition number:
2022/04
Publication date:
04/03/2022
Description:
Section K : Modifications and recordals into the register

Deed

Licence

Change Kind/ Decision Type:
New licence registration
Deed Number:
RC20220000048B
Date Registered:
16/02/2022
Licence Effective Date:
06/07/2021
Licence Expiration Date:
28/02/2022
Scope of Licence:
Not Exclusive
Deed Filer:
ETUDE DECKER ET BRAUN
Journal Edition Number:
Text:
Country Code:
Luxembourg (LU)
Updated Licence Number:
Terminated Licence Number:

Added Licencee(s)

Name:
NOVARTIS PHARMA NV
Address:
Medialaan 40, 1800, Vilvoorde, Belgium (BE)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
08/06/2016
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
MARKS & CLERK (Luxembourg) LLP
Filing date Document type Number of pages
17/02/2022 Request For Change 5
21/02/2022 Outgoing Correspondence 1